公开(公告)号：US20200306066A1

公开(公告)日：2020-10-01

申请号：US16367922

申请日：2019-03-28

Applicant: Medtronic Vascular, Inc.

Inventor： Keith Perkins ,  Zachary Borglin ,  Mark Stiger ,  Julie Benton ,  Steven Claessens ,  Travis Rowe ,  Mark Young

IPC: A61F2/90 ,  A61F2/07 ,  A61F2/89

Abstract: The techniques of this disclosure generally relate to a modular stent device that is deployed into the ascending aorta via femoral access. The modular stent device is a base or anchor component to which additional modular stent devices can be attached to exclude diseased areas of the aorta while at the same time allowing perfusion of the brachiocephalic artery, the left common carotid artery, and/or the left subclavian artery.

公开(公告)号：US11617641B2

公开(公告)日：2023-04-04

申请号：US17354629

申请日：2021-06-22

Applicant: Medtronic Vascular, Inc.

Inventor： Keith Perkins ,  Mark Stiger ,  Steven Claessens

IPC: A61F2/07 ,  A61F2/848

Abstract: Systems and methods for building a landing zone for an endovascular procedure are described. This procedure is “hybrid” in that it involves both direct access (e.g., sternotomy or partial sternotomy) to the site for installation of the landing zone, as well as endovascular installation of a TAVR or TEVAR device (e.g., stent graft) once the landing zone is installed. The landing zone is installed by wrapping a landing band around a portion of a vessel. The landing band may be selected to be fixed at a diameter so that it inhibits any expansion of the vessel, and also supports a later-installed TAVR or TEVAR device. The TAVR or TEVAR device is then endovascularly delivered to the vessel and deployed therein. The device expands until it contacts the vessel, which is supported from the outside by the landing band, which thus constrains and supports the device from outside.

公开(公告)号：US11344402B2

公开(公告)日：2022-05-31

申请号：US16855780

申请日：2020-04-22

Applicant: Medtronic Vascular, Inc.

Inventor： Keith Perkins ,  Travis Rowe ,  Mark Stiger ,  Mark Young ,  Julie Benton ,  Steven Claessens

IPC: A61F2/07 ,  A61F2/954 ,  A61F2/856 ,  A61F2/06

Abstract: The techniques of this disclosure generally relate to a stent-graft system including a bifurcated stent-graft, a first bifurcating branch device, and a first branch extension. The bifurcated stent-graft includes a body, a first branch limb, and a second branch limb. The first bifurcating branch device includes a body segment coupled to the first branch limb of the bifurcated stent-graft, a first branch limb, and a second branch limb. The first branch extension is within the first branch limb of the first bifurcating branch device and within an external iliac artery. The first bifurcating branch device has a wide patient applicability since the treatment can be extended proximal to the anatomical iliac bifurcation and is not limited by the common iliac artery length. The stent-graft system is suitable to treat a wide range of internal and external iliac artery diameters.

公开(公告)号：US20210322188A1

公开(公告)日：2021-10-21

申请号：US17362644

申请日：2021-06-29

Applicant: Medtronic Vascular, Inc.

Inventor： Keith Perkins ,  Zachary Borglin ,  Mark Stiger ,  Julie Benton ,  Steven Claessens ,  Travis Rowe ,  Mark Young

IPC: A61F2/90 ,  A61F2/07 ,  A61F2/89 ,  A61F2/852 ,  A61F2/856

Abstract: The techniques of this disclosure generally relate to a modular stent device that is deployed into the ascending aorta via femoral access. The modular stent device is a base or anchor component to which additional modular stent devices can be attached to exclude diseased areas of the aorta while at the same time allowing perfusion of the brachiocephalic artery, the left common carotid artery, and/or the left subclavian artery.

公开(公告)号：US11083605B2

公开(公告)日：2021-08-10

申请号：US16367922

申请日：2019-03-28

Applicant: Medtronic Vascular, Inc.

Inventor： Keith Perkins ,  Zachary Borglin ,  Mark Stiger ,  Julie Benton ,  Steven Claessens ,  Travis Rowe ,  Mark Young

IPC: A61F2/07 ,  A61F2/852 ,  A61F2/856 ,  A61F2/90 ,  A61F2/89 ,  A61F2/954 ,  A61F2/06

Abstract: The techniques of this disclosure generally relate to a modular stent device that is deployed into the ascending aorta via femoral access. The modular stent device is a base or anchor component to which additional modular stent devices can be attached to exclude diseased areas of the aorta while at the same time allowing perfusion of the brachiocephalic artery, the left common carotid artery, and/or the left subclavian artery.

公开(公告)号：US20200306064A1

公开(公告)日：2020-10-01

申请号：US16367906

申请日：2019-03-28

Applicant: Medtronic Vascular, Inc.

Inventor： Keith Perkins ,  Zachary Borglin ,  Mark Stiger ,  Julie Benton ,  Steven Claessens ,  Travis Rowe ,  Mark Young

IPC: A61F2/852 ,  A61F2/07

Abstract: The techniques of this disclosure generally relate to a modular stent device that is deployed via supra aortic access through the brachiocephalic artery. The modular stent device is a base or anchor component to which additional modular stent devices can be attached to exclude diseased areas of the aorta while at the same time allowing perfusion of the left common carotid artery and the left subclavian artery.